Profit

Nova Specialty Not EPS Dilutive: Apollo Health

PUBLISHED ON: January 7, 2015 | Duration: 5 min, 02 sec

facebooktwitteremailkoo
loading..
Neeraj Garg, CEO at Apollo Health & Lifestyle, speaks to NDTV about the buyout of Nova Specialty for Rs 145 crore. He says the deal will be financed by a mix of both debt and equity, and will not be EPS dilutive.
ALSO WATCH
'My Health, My Right': Understanding The World Health Day 2024 Theme

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com